Shawn Morgan

  • x-ray of lungs with a suspicious spot highlighted in red

    VICC trial putting lung cancer therapy to the test

    Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis. Read More

    Oct 20, 2016